Blockade of ELR+CXC chemokines as a treatment for inflammatory and autoimmune disease

Details for Australian Patent Application No. 2006204133 (hide)

Owner University of Rochester

Inventors Segal, Benjamin; Carlson, Thaddeus

Agent Griffith Hack

Pub. Number AU-A-2006204133

PCT Pub. Number WO2006/074179

Priority 60/641,323 04.01.05 US

Filing date 4 January 2006

Wipo publication date 13 July 2006

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/074179 Priority application(s): WO2006/074179

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204136-Compositions comprising Oacetylsalicyl derivatives of aminocarbohydrates and amino acids

2006204127-Water-absorbent adhesive compositions and associated methods of manufacture and use